ScreenerHero

SANA Sana Biotechnology, Inc.

NAS · US · Healthcare · Biotechnology · sana.com
2.720USD-1.09%Mkt Cap: 814.26M $P/E: —

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap814.26M USD
Enterprise Value743.69M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-244.17M USD
Revenue/Share—
Last Price2.720 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.95
PEG—
EV/EBITDA-4.27
EV/Revenue—
P/S—
P/B5.33
EPS (TTM)-0.73
EPS (Forward)-0.56
52W Range
2.6103% of range6.550
52W High6.550 USD
52W Low2.610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-151.77%
ROA-58.57%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-143.83M USD
CapEx (TTM)938.00K USD
FCF Margin—
FCF Yield0.51%
Net Debt-79.55M USD
Net Debt/EBITDA0.46
Balance Sheet
Debt/Equity0.49
Current Ratio1.38
Quick Ratio1.30
Book Value/Sh0.52 USD
Cash/Share0.54 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.429 USD
Upside (mean)+209.9%
Target Range6.000 USD – 12.00 USD
6.000+209.9% to mean12.00
# Analysts7
Ownership
Shares Out.299.36M
Float190.90M
Insiders6.08%
Institutions77.70%
Short Interest
Short Ratio13.8d
Short % Float23.33%
Short % Out.13.82%
Shares Short41.37M
Short (prev mo.)42.57M
Technical
SMA 503.423 (-20.5%)
SMA 2003.577 (-24.0%)
Beta2.19
S&P 52W Chg16.45%
Avg Vol (30d)3.85M
Avg Vol (10d)3.86M
Technical Indicators
RSI (14)31.7
MACD-0.1944
MACD Signal-0.1665
MACD Hist.-0.0279
BB Upper3.587 USD
BB Middle3.067 USD
BB Lower2.548 USD
BB Width33.89%
ATR (14)0.2025 USD
Vol Ratio (20d)0.99x